Literature DB >> 7729266

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A.

J C Duclos-Vallée1, A Hadengue, N Ganne-Carrié, E Robin, C Degott, S Erlinger.   

Abstract

We report a case of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome treated with cyclosporine A. Features of primary biliary cirrhosis were pruritus, high titer of antimitochondrial antibodies, inflammatory infiltrates surrounding interlobular bile ducts, and periportal granuloma. Features suggestive of autoimmune hepatitis were high titer of antinuclear antibodies, very high total immunoglobulins, and piecemeal necrosis. Because corticosteroids and ursodeoxycholic acid were inefficient, cyclosporine A was started at a dose of 3 mg/kg/day. A dramatic improvement in clinical condition, liver tests, and histology was noted. Discontinuation of cyclosporine A was followed by a clinical and histological relapse. Cyclosporine A reintroduction was again associated with a significant improvement. This case report suggests that in corticoresistant cases cyclosporine A could be an effective therapy for primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729266     DOI: 10.1007/bf02064201

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  A 33-year-old woman with an autoimmune syndrome.

Authors:  J G Carrougher; R T Shaffer; L I Canales; Z D Goodman
Journal:  Semin Liver Dis       Date:  1991-08       Impact factor: 6.115

Review 2.  A unified concept of autoimmune hepatitis.

Authors:  D Doniach; J G Walker
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

Review 3.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

4.  Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; A H Baggenstoss; W H Summerskill
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

5.  A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.

Authors:  R H Wiesner; J Ludwig; K D Lindor; R A Jorgensen; W P Baldus; H A Homburger; E R Dickson
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

6.  Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse.

Authors:  Y Calmus; B Weill; Y Ozier; C Chéreau; D Houssin; R Poupon
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

7.  Cyclosporine treatment of autoimmune chronic active hepatitis.

Authors:  J S Hyams; M Ballow; A M Leichtner
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

8.  Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial.

Authors:  M Lombard; B Portmann; J Neuberger; R Williams; N Tygstrup; L Ranek; H Ring-Larsen; J Rodes; M Navasa; C Trepo
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

9.  Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity.

Authors:  G Klöppel; G Seifert; H Lindner; R Dammermann; H J Sack; P A Berg
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-03-11

10.  Autoimmune associations in primary biliary cirrhosis.

Authors:  K S Culp; C R Fleming; J Duffy; W P Baldus; E R Dickson
Journal:  Mayo Clin Proc       Date:  1982-06       Impact factor: 7.616

  10 in total
  9 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.

Authors:  R Malekzadeh; S Nasseri-Moghaddam; M J Kaviani; H Taheri; N Kamalian; M Sotoudeh
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

3.  Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation.

Authors:  Yong-Zhen Kang; Xiao-Ye Sun; Yi-He Liu; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 4.  [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

Review 5.  The overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

Review 6.  Overlap syndromes among autoimmune liver diseases.

Authors:  Christian Rust; Ulrich Beuers
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 7.  Overlap syndromes of autoimmune hepatitis: what is known so far.

Authors:  Marilena Durazzo; Alberto Premoli; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

Review 8.  Overlap syndromes: an emerging diagnostic and therapeutic challenge.

Authors:  Pooja Dhiman; Sharad Malhotra
Journal:  Saudi J Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 2.485

Review 9.  Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Benjamin L Freedman; Christopher J Danford; Vilas Patwardhan; Alan Bonder
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.